Trial intelligence / Profile preview

IZN-6N4 for Prevention of Oral Mucositis in Head and Neck Cancer

NCT01400620Phase 2Completed

Sponsor
Izun Pharmaceuticals
Start
Mar 2012
Primary completion
Jan 2017
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of botanical extracts rinse IZN-6N4 in oral mucositis (OM), sponsored by Izun Pharmaceuticals. Started Mar 2012; status: completed.

02

Drugs

botanical extracts rinse IZN-6N4
03

Conditions

oral mucositis (OM)

Beyond the preview

Go deeper on NCT01400620.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01400620.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call